Literature DB >> 4613321

Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine.

R D Sweet, R Bruun, E Shapiro, A K Shapiro.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4613321     DOI: 10.1001/archpsyc.1974.01760180095012

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  10 in total

Review 1.  Assessment of extrapyramidal disorders.

Authors:  C D Marsden; M Schachter
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

Review 2.  Gilles de la Tourette syndrome: symptomatic treatment based on evidence.

Authors:  M M Robertson; J S Stern
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

3.  Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test.

Authors:  D E Grice; J F Leckman; D L Pauls; R Kurlan; K K Kidd; A J Pakstis; F M Chang; J D Buxbaum; D J Cohen; J Gelernter
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

4.  Tardive dyskinesia: a clinical test of the supersensitivity hypothesis.

Authors:  M B Bowers; D Moore; D Tarsy
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

5.  Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome.

Authors:  Neal R Swerdlow; Michele J Bongiovanni; Laura Tochen; Jody M Shoemaker
Journal:  Psychopharmacology (Berl)       Date:  2006-04-01       Impact factor: 4.530

Review 6.  alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

Review 7.  Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.

Authors:  Thomas S Guillot; Gary W Miller
Journal:  Mol Neurobiol       Date:  2009-03-04       Impact factor: 5.590

Review 8.  Tetrabenazine: Spotlight on Drug Review.

Authors:  Navneet Kaur; Puneet Kumar; Sumit Jamwal; Rahul Deshmukh; Vinod Gauttam
Journal:  Ann Neurosci       Date:  2016-09-09

9.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

10.  Tourette syndrome research highlights from 2017.

Authors:  Andreas Hartmann; Yulia Worbe; Kevin J Black
Journal:  F1000Res       Date:  2018-07-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.